Stockreport

Why OpenAI's drug royalties deal won't work [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF OpenAI's software for free to biotech companies in exchange for royalties on any drugs they might develop. It's not going to work. Biotech companies are doing a lot of [Read more]